We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

FAPON

Fapon is a global IVD raw materials & one-stop solutions company offering 700+ reagent raw materials for the applicat... read more Featured Products: More products

Download Mobile App





Fapon Biotech Presents Latest IVD Innovations at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 09 Feb 2023

Fapon Biotech (Guangdong, China) is presenting its latest IVD innovations at the 22nd edition of Medlab Middle East Congress taking place live, in-person from 6-9 February 2023. More...

As a leading supplier of IVD raw materials and customized solutions, Fapon has continuously developed and optimized its product portfolio to accelerate disease testing for downstream diagnostic companies. Fapon provides over 1300 antibodies, antigens, enzymes, blockers, and more on different technology platforms of chemiluminescence, ELISA, rapid test, immunoturbidimetry, PCR and NGS. At Medlab Middle East 2023, Fapon is introducing its wide range of raw materials and reagent services, such as cardiac marker, tumor marker, respiratory disease, inflammatory marker, tropical disease, infectious disease, drug of abuse, polymerase & mix, reverse transcriptase & mix, LAMP polymerase, PCR miscellaneous, and many more.

Fapon is also presenting its self-developed series of high-performance chemiluminescence immunoassay analyzers that are open and fully customizable. This includes Shine i1000, the smallest fully automatic chemiluminescence immunoassay analyzer, as well as the Shine i2000 compact yet robust and large capacity IVDR certified analyzer which is compatible with AE, AP, HRP, ABEI protocols. In addition, Fapon is showcasing the P810 real-time PCR analyzer and the iCatch2000 rapid molecular point-of-care analyzer. Equipped with Fapon’s core raw materials and reagent services, these instruments provide a one-stop solution for chemiluminescence immunoassay and ultra-fast PCR, respectively.

Related Links:
Fapon Biotech


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Serological Pipet Controller
PIPETBOY GENIUS
New
Legionella Pneumophila Test
CHORUS Legionella Urinary Antigen
New
Modular Hemostasis Automation Solution
CN Track
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.